Project Grant R21AG091384
Award Date
1/1/25
Completion Date
12/31/26
Dollars Obligated
$419K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32611, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $369,823 to the University of South Florida to investigate the role of SARS-CoV-2-induced cellular senescence in the development of Alzheimer's disease. The key objectives are to explore how SARS-CoV-2 and its S1 protein subunit promote cellular senescence in the brain,...
This three-year, $6.5 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund research under the Aging Research program (CFDA 93.866). The grantee, the Regents of the University of Minnesota, will assess the acute and long-term impacts of SARS-CoV-2 infection on cognitive function and neuropathology in aging and Alzheimer's disease. Specifically, the University of Minnesota researchers will test hypotheses about how the...
This $3,659,973 Project Grant was awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of South Florida. The grant supports a multi-year research initiative to investigate the molecular mechanisms underlying the neurological sequelae, known as "Neuro-COVID," observed in some COVID-19 patients. The key objectives are to: Assess how aging exacerbates inflammation and tauopathy (abnormal tau protein buildup) following COVID-19 infection in mouse...
This three-year, $4.68 million Project Grant from the National Institute on Aging, part of the Department of Health and Human Services, will support research into the collision of Alzheimer's disease and the COVID-19 pandemic in the United States. Funded under the Aging Research program, the grantee Case Western Reserve University will utilize a nationwide electronic health records database of over 80 million patients to examine COVID-19 risks and outcomes for those with Alzheimer's, including...
The National Institute on Aging (NIA) awarded a 3-year, $2,561,480 Project Grant (CFDA 93.866) to Brigham & Women's Hospital to study the post-acute sequelae of SARS-CoV-2 infection (PASC) and subsequent disease progression in individuals with mild cognitive impairment (MCI) or Alzheimer's disease (AD) and related dementias (ADRD). The project aims to: 1) understand the epidemiology of PASC in cognitively impaired individuals; 2) examine the impacts of COVID-19 and PASC on disease...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $630,000 to the University of Rhode Island to investigate the impact of SARS-CoV-2 infection on a novel transgenic rat model of cerebral amyloid angiopathy (CAA). The two-year project, running from September 2024 to May 2026, aims to determine if the SARS-CoV-2 spike protein accelerates the emergence and progression of CAA pathology, as well as exacerbates associated vasculopathies in...
This $794,341 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) is supporting research to investigate the role of cellular senescence and blood-brain barrier dysfunction in Alzheimer's disease progression. The research project, led by the University of Illinois, aims to elucidate how viral and bacterial pathogens can initiate blood-brain barrier dysfunction and cellular senescence, which in turn promote neuroinflammation and Alzheimer's disease...
This $200,323 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will support research by the University of South Florida to investigate the aggregation of amyloid-beta (Aβ) peptides during metabolic stress and spreading depolarization events in the brain. The project will utilize multiscale modeling, high-resolution microscopy, antibody staining, and paralysis phenotype testing in C. elegans to determine how physiochemical changes...
The National Institute on Aging (NIA) awarded a $1,281,004 Project Grant under the Aging Research federal grant program (CFDA 93.866) to The University of North Carolina at Charlotte to investigate the interactions between viral infection, tau pathology, and neuroinflammation. The 3-year research project aims to determine whether viral infection increases tau pathology, assess the impact of tau aggregation on viral replication, and examine the effect of tau pathology on the neuroinflammatory...
The National Institute on Aging (NIA) awarded a $828,534 Cooperative Agreement under the Aging Research federal grant program (CFDA 93.866) to the University of Massachusetts Medical School (UMass Medical) to conduct a molecular dissection of the neuronal-adaptive immune-genomic axis. The goal is to identify novel integrative factors contributing to Alzheimer's disease (AD) pathogenesis or to the protection of brain neurons in the aging process. The project will apply large-scale, innovative,...